Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shibata

Showing results (101-110 of 159) with videos related to

Pageof 16
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 1, 1996
[High uptake of N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) demonstrated by dynamic SPECT in some cases of glioma]N Sugou, I Shibata, A Nemoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1980
[Aplasia of body and tail of the pancreas.--A report of two cases (author's transl)]M Morita, C Otsubo, T Kozu, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1979
[A case of chronic calcifying pancreatitis associated with familial primary hyperparathyroidism suggesting multiple endocrine adenomatosis (type I) (author's transl)]K Shiratori, T Kozu, I Shibata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
British Journal of Cancer|June 13, 2001
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcomeG Somlo, J H Doroshow, T Synold, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignanciesS I Shibata, R Pezner, D Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
Pageof 16

Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 1, 1996
[High uptake of N-isopropyl-p-[123I]-iodoamphetamine (123I-IMP) demonstrated by dynamic SPECT in some cases of glioma]N Sugou, I Shibata, A Nemoto, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1980
[Aplasia of body and tail of the pancreas.--A report of two cases (author's transl)]M Morita, C Otsubo, T Kozu, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 1, 1979
[A case of chronic calcifying pancreatitis associated with familial primary hyperparathyroidism suggesting multiple endocrine adenomatosis (type I) (author's transl)]K Shiratori, T Kozu, I Shibata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
British Journal of Cancer|June 13, 2001
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcomeG Somlo, J H Doroshow, T Synold, et al.
American Journal of Clinical Oncology|October 11, 2008
Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium TrialY Yen, Dean W Lim, Vincent Chung, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 17, 2004
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignanciesS I Shibata, R Pezner, D Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group studyStephen I Shibata, Vincent Chung, Timothy W Synold, et al.
Pageof 16